You are here

Xtacy Therapeutics Corp.

Xtacy Therapeutics Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Diversified Industries
Symbol: 
XTCY
CSE Index: 
Currency: 

Xtacy Therapeutics Corp is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The present focus of the company is in hemp and CBD-related, psilocybin and functional mushrooms, and health-care related industries.

You are here

Xtacy Therapeutics Corp. (XTCY)

SEDAR Information

Company Info

Address
Suite 1100- 1111 Melville Street
Vancouver, BC V6E 3V6
Canada
Phone
604-484-0355
Fax
604-608-5442
Email
Info@globalwellnessstrategies.com
Website
https://xtacytherapeutics.com/
Listing date
Thursday, July 16, 2009
Transfer Agent
Computershare Investor Services Inc.
Investor Relations
604-484-0355
Email
Info@globalwellnessstrategies.com
Auditor
SHIM & Associates LLP

Capitalization

Issued & Outstanding: 
54576471
Reserved for Issuance: 
3353890

Company Officers

Meris Kott, Director, CEO
Lindsey Perry Jr., Director and CFO
Ashleigh Vogstad, Director

Bulletins

25/09/2023

2023-0929 - Name and Symbol Change - Global Wellness Strategies Inc. (GWS)

le 25 septembre/September 2023

Global Wellness Strategies Inc. (GWS) has announced a name and symbol change to Xtacy Therapeutics Corp. (XTCY)

Shares will begin trading under the new name and symbol and with a new CUSIP number on September 26, 2023.

Disclosure documents are available at www.thecse.com.